New York, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Intravenous Iron Drugs Market- Global Industry Size, Share, Trends ...

Purpose: The frequency of drug administration errors and incompatibilities between intravenous drugs before and after an intervention in an intensive care unit (ICU) is discussed. Methods: Critically ...

Ithaca mayor outlined possible "safe" space for intravenous drug users. — -- The town of Ithaca, New York, is contemplating the creation of "safe" spaces for drug users, highlighting how some ...

A recent study found that women had varying levels of willingness to use long-acting injectable HIV medications, based on their history with intravenous drug use. The researchers said that differences ...

Dublin, July 09, 2025 (GLOBE NEWSWIRE) -- The "Intravenous Iron Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type" ...

The World Health Organization (WHO) released a report this month called "Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations." It assessed several different ...

A daily dose of powerful anti-HIV medicine helped cut the risk of infection with the AIDS virus by 49 percent in intravenous drug users in a Bangkok study that showed for the first time such a ...

One IV treatment of the investigational flu drug peramivir works as well as five days of Tamiflu pills, suggests a large study that pitted one drug against the other. An injectable flu drug is badly ...

-CONTEPO is a potential first-in-class intravenous antibiotic in U.S. for the treatment of complicated urinary tract infections The NDA for CONTEPO was resubmitted based on the outcome and final ...

Hepatitis C is a viral infection that causes liver inflammation and, at times, results in major damage to your liver. The virus that causes it spreads through blood and other bodily fluids. If you ...

YPSILANTI (WWJ) --Integrated Sensing Systems Inc. announced that the United States Patent Office has granted it U.S. Patent No. 8,016,798 for "Fluid Delivery System and Sensing Unit." ISSYS, as ...

After approval of the study protocol by the ethics committee of the Medical Faculty of the University of Heidelberg, we evaluated parenteral drug treatment in patients admitted to a 12-bed ICU in a ...